Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review

Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company which carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada, and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company

Sinphar Pharmaceutical Co Ltd - Key Facts
Sinphar Pharmaceutical Co Ltd - Key Employees
Sinphar Pharmaceutical Co Ltd - Key Employee Biographies
Sinphar Pharmaceutical Co Ltd - Major Products and Services
Sinphar Pharmaceutical Co Ltd - History
Sinphar Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
Sinphar Pharmaceutical Co Ltd - Business Description
Sinphar Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sinphar Pharmaceutical Co Ltd - Strengths
Sinphar Pharmaceutical Co Ltd - Weaknesses
Sinphar Pharmaceutical Co Ltd - Opportunities
Sinphar Pharmaceutical Co Ltd - Threats
Sinphar Pharmaceutical Co Ltd - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 - Appendix

Methodology
Ratio Definitions
About the Publisher
Contact the Publisher
Disclaimer

List of Tables

Sinphar Pharmaceutical Co Ltd, Key Facts
Sinphar Pharmaceutical Co Ltd, Key Employees
Sinphar Pharmaceutical Co Ltd, Key Employee Biographies
Sinphar Pharmaceutical Co Ltd, Major Products and Services
Sinphar Pharmaceutical Co Ltd, History
Sinphar Pharmaceutical Co Ltd, Subsidiaries
Sinphar Pharmaceutical Co Ltd, Key Competitors
Sinphar Pharmaceutical Co Ltd, Annual Ratios
Sinphar Pharmaceutical Co Ltd, Interim Ratios
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Sinphar Pharmaceutical Co Ltd, Performance Chart (2017 - 2021)
Sinphar Pharmaceutical Co Ltd, Ratio Charts
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023